Global prevalence of chronic migraine: A systematic review
Cerner (United States) · Allergan (United States) · +3 more institutions
Abstract
The aim of this review was to summarize population-based studies reporting prevalence and/or incidence of chronic migraine (CM) and to explore variation across studies. A systematic literature search was conducted. Relevant data were abstracted and estimates were subdivided based on the criteria used in each study. Sixteen publications representing 12 studies were accepted. None presented data on CM incidence. The prevalence of CM was 0-5.1%, with estimates typically in the range of 1.4-2.2%. Seven studies used Silberstein-Lipton criteria (or equivalent), with prevalence ranging from 0.9% to 5.1%. Three estimates used migraine that occurred ≥15 days per month, with prevalence ranging from 0 to 0.7%. Prevalence…
Citation impact
- FWCI
- 10.67
- Percentile
- 100%
- References
- 36
Authors
7Topics & keywords
- Medicine
- Migraine
- Epidemiology
- Prevalence
- Incidence (geometry)
- Population
- MEDLINE
- Chronic Migraine
- Good health and well-being